Seeyond Nektar Therapeutics Transaction History

Seeyond

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$15.87 - $23.12 $99,489 - $144,939	-6,269 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$16.91 - $36.27 $40,837 - $87,592	2,415 Added 62.66%	6,269 $114,000
Q2 2019 Aug 13, 2019	SELL	$31.0 - $36.3 $26,195 - $30,673	-845 Reduced 17.98%	3,854 $137,000
Q4 2018 Feb 14, 2019	BUY	$30.43 - $56.65 $142,990 - $266,198	4,699 New	4,699 $154,000

140

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Seeyond, based on Form 13F filings with the SEC.

Stay updated on Seeyond with notifications on news.